{"id":7671,"date":"2023-07-14T18:23:43","date_gmt":"2023-07-14T18:23:43","guid":{"rendered":"https:\/\/www.caltagmedsystems.co.uk\/information\/?p=7671"},"modified":"2023-07-14T18:23:43","modified_gmt":"2023-07-14T18:23:43","slug":"leadgene-utilizes-leadsphere-lyophilization-technology-to-make-reagents-stable-for-long-term-logistics-press-release","status":"publish","type":"post","link":"https:\/\/www.caltagmedsystems.co.uk\/information\/leadgene-utilizes-leadsphere-lyophilization-technology-to-make-reagents-stable-for-long-term-logistics-press-release\/","title":{"rendered":"Leadgene Utilizes LEADSPHERE™ Lyophilization Technology to Make Reagents Stable for Long-Term Logistics – Press release"},"content":{"rendered":"\n
\"\"<\/a><\/figure>\n\n\n\n

TAINAN, Taiwan, August 30, 2022<\/strong> (Newswire.com) – Leadgene Biomedical, Inc., an ISO-certificated contract development and manufacturing organization (CDMO) company that provides integrated service for in-vitro diagnostics (IVD) products from the development to manufacturing process, has announced the launch of its LEADSPHERE™ Lyophilization Technology to aid in the dispense, storage, and transport of reagents for use in biomolecule analysis tools.<\/p>\n\n\n\n

“Leadgene has established a reputation for providing a comprehensive solution for biotech companies in the area of high-performance assay kits development,” said Dr.  Yung-Chun Chuang, Chairman of the Board and Chief Technology Officer of Leadgene, “LEADSPHERE™ Lyophilization Technology enables assay reagents to be stable in non-liquid form at room temperature, and allows for the assembling of the entire kit in a large-scale-production manner through a ‘pick and place’ automation system.”<\/p>\n\n\n\n

Numerous advantages of freeze-drying reagents in sphere format have been documented, with the most significant one being the ability to sustain the ingredients’ activities at room temperature. LEADSPHERE™ Lyophilization Technology is an automated dispensing system composed of all the necessary parts to freeze dry materials in low volume (10~20 microliter). The final product is a stable lyophilized sphere with a consistent diameter of ~3 mm, and therefore, makes it suitable for all sizes of microplates and microtubes. A successful example that utilises LEADSPHERE™ Lyophilization Technology is the LEADSPHERE™ Proteinase K, an endopeptidase used for nucleic acids sample preparation by digesting proteins and inactivating ribonuclease. The features of this product include:<\/p>\n\n\n\n